Log in to save to my catalogue

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8eb773cdff2e47a6b6e25cd27c64f576

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

About this item

Full title

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2022-03, Vol.132 (6), p.1-12

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

The COVID-19 pandemic has elevated mRNA vaccines to global recognition due to their unprecedented success rate in protecting against a deadly virus. This international success is underscored by the remarkable versatility, favorable immunogenicity, and overall safety of the mRNA platform in diverse populations. Although mRNA vaccines have been studi...

Alternative Titles

Full title

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8eb773cdff2e47a6b6e25cd27c64f576

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8eb773cdff2e47a6b6e25cd27c64f576

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI156211

How to access this item